Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shelun Tsai has a total of 53 co-authors. Here are the top co-authors by number of shared publications:

  • Jennifer L. Eaton

    Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Women and Infants Hospital and Warren Alpert Medical School of Brown University, Providence, Rhode Island

    3 shared publications
  • Tracy Truong

    Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, USA

    3 shared publications
  • Elizabeth Deans

    Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, USA

    2 shared publications
  • Melinda L. Asbury

    Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, USA

    2 shared publications
  • Steven Spandorfer

    Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medical College, New York, New York

    2 shared publications
  • Aleksandra Uzelac

    University of Toronto, Temerty Faculty of Medicine, Toronto, ON

    1 shared publication

Latest Publications

  • Secrets and lies and donor conceptions: what donor-conceived individuals feel about their disclosure/discovery experience

    by Linda D Applegarth, Nancy L Kaufman, Charlene Thomas, Gabriela Beroukhim, Shelun Tsai, Mitasha Joseph-Sohan

    STUDY QUESTION: What are the satisfaction levels, as defined by emotional comfort or contentment, of adult individuals conceived via donor-assisted reproduction concerning the method, timing, and circumstances surrounding the disclosure/discovery of their conception? SUMMARY ANSWER: Inadvertent discovery and older age at the time of disclosure of donor-conceived status are associated with lower rates of satisfaction among donor-conceived individuals. WHAT IS KNOWN ALREADY: The proliferation of commercial DNA testing has resulted in many donor-conceived people learning inadvertently of their donor origins. As a result, donor-conceived people, healthcare professionals, and parents seek information and research about best disclosure practices and outcomes. STUDY DESIGN, SIZE, DURATION: A survey-based cross-sectional cohort study from 2022 to 2023 was conducted involving 530 participants, of whom 422 completed the survey. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 546 people ages 18 years and over opened the survey, with 530 people qualifying to complete the survey as donor-conceived persons (DCPs). Four hundred and twenty-two DCPs (79.6%) completed the survey. Descriptive statistics were applied, and data distributions were analyzed for a selection of appropriate statistical tests; parametric tests such as Student’s t-test or ANOVA, and non-parametric tests such as Mann U Whitney or Kruskal-Wallis Rank Sum test were utilized as applicable, for comparing continuous data between groups. Multivariable logistic regression analyses were used to examine satisfaction levels, adjusting for potential confounders. MAIN RESULTS AND THE ROLE OF CHANCE: After accounting for age at discovery, sex, the origin of disclosure, and education, individuals with early intentional disclosure were more than three times as likely to experience disclosure satisfaction as those with late unintentional disclosure/inadvertent discovery (P-value = 0.005) LIMITATIONS, REASONS FOR CAUTION: Lack of ethnic diversity among survey respondents, and limited control over reposting of the survey to other sites, potentially contributing to sampling bias. WIDER IMPLICATIONS OF THE FINDINGS: Preliminary but substantial evidence that early, intentional disclosure to DCPs results in greater satisfaction and acceptance. This data will ultimately assist all stakeholders, including reproductive health professionals and parents in family-building counseling and decision-making. STUDY FUNDING/COMPETING INTEREST(s): None. TRIAL REGISTRATION NUMBER: N/A.


  • Optimizing the number of cryopreserved donor oocytes to fertilize with a focus on minimizing excess embryos

    by S Tsai, X Ma, S Spring, S Spandorfer

    STUDY QUESTION: What is the optimal number of frozen donor oocytes to thaw and fertilize to achieve one live birth while minimizing supernumerary embryos? SUMMARY ANSWER: For patients who want only one child, fertilizing 6–7 frozen donor oocytes would result in approximately one supernumerary embryo while maintaining the live birth rate. WHAT IS ALREADY KNOWN: Studies on frozen donor oocyte outcomes focus on live birth rate, but little is known about the resulting number of supernumerary embryos. STUDY DESIGN, SIZE, DURATION: This is a retrospective cohort study using data from the 2016–2020 Society for Assisted Reproductive Technology Clinic Outcomes Reporting System. A total of 11,554 frozen donor oocyte recipients undergoing their first cycle with frozen donor oocytes were included. PARTICIPANTS/MATERIALS, SETTING, METHODS: The 11,554 frozen donor oocyte recipients were stratified into quartiles based on the number of frozen donor oocytes thawed (7). The primary outcome was the number of supernumerary blastocysts, defined as the number of blastocysts remaining after the first live birth, or at the final transfer cycle if the patient did not have a live birth. MAIN RESULTS AND THE ROLE OF CHANCE: On average, patients thawed 6.74 ± 1.96 oocytes, resulting in 4.77 ± 2.07 2PNs (2 pronuclei), 2.44 ± 1.59 usable embryos, and 1.02 ± 1.47 supernumerary blastocysts. The average number of cryopreserved supernumerary blastocysts increased as the number of frozen donor oocytes thawed increased (0.50 vs. 0.90 vs. 0.99 vs. 1.49 blastocysts in each quartile, respectively, P<0.01). However, live birth rates were only significantly lower when less than six frozen donor oocytes were thawed and fertilized (37.6% vs. 48.5% vs. 50.3% vs. 51.3%, P<0.01). LIMITATIONS, REASONS FOR CAUTION: There are limitations to utilizing national databases, including missing data and the inability to extrapolate additional nuanced information not originally collected. WIDER IMPLICATIONS OF THE FINDINGS: The number of supernumerary blastocysts increases even with small increases in the number of frozen donor oocytes exposed to sperm. While thawing 6–7 frozen donor oocytes aligns with most practices, almost a quarter of patients thawed more than 7 frozen donor oocytes, which led to a significant increase in the number of supernumerary embryos to 1.49 without a significant increase in live birth rate. STUDY FUNDING/COMPETING INTEREST(S): Xiaoyue Ma, MSc is partially supported by the following grant: Clinical and Translational Science Center at Weill Cornell Medical College (1-UL1-TR002384-01). Steven Spandorfer is a former President of the Society for Assisted Reproductive Technology. TRIAL REGISTRATION NUMBER: Not applicable.

  • Open Access

    Analysis of Surplus Cryopreserved Blastocysts in Fresh Donor Oocyte Cycles

    by Shelun Tsai, Xiaoyue Ma, Samantha Spring, Steven Spandorfer

    Importance: Excess cryopreserved embryos present financial, logistical, and ethical constraints on patients and fertility clinics that are further complicated by the recently evolving US judicial landscape that may alter the legal status of frozen embryos and limit disposition options. It is therefore important to consider limiting the number of supernumerary embryos created from fresh donor oocytes.Objective: To determine the optimal number of fresh donor oocytes to fertilize to achieve 1 live birth while minimizing supernumerary blastocysts.Design, Setting, and Participants: This cohort study used data from recipients of fresh donor oocytes at member clinics of the Society for Assisted Reproductive Technology Clinic Outcomes Report System (SART CORS) between January 1, 2016, and December 31, 2020. Data were analyzed between August 2023 and June 2024.Main Outcomes and Measures: The number of supernumerary blastocysts for a given number of fresh donor oocytes retrieved.Results: There were 9395 fresh donor oocyte recipients included. The median (IQR) oocyte donor age at oocyte retrieval was 26 years (24-28 years), and the median (IQR) patient age at cycle start was 42 years (38-45 years). The median (IQR) number of oocytes retrieved was 20 (14-28), fertilized oocytes (2 pronuclei [2PN]) was 11 (7-17), usable embryos was 6 (3-10), and supernumerary blastocysts was 5 (2-8). When patients were divided evenly into quartiles based on the number of fresh donor oocytes retrieved (14 or fewer, 15 to 20, 21 to 28, 29 or more), it was associated with a significant increase in the number of cryopreserved supernumerary blastocysts (median [IQR] blastocysts by quartile: 2 [1-4] vs 4 [2-7] vs 6 [3-9] vs 9 [4-14], respectively; P < .001). However, the live birth rate was lower only for those in the first quartile receiving 14 or fewer oocytes (50.8% [1207 of 2376] vs 64.1% [1497 of 2336] vs 67.9% [1631 of 2401] vs 67.9% [1550 of 2282]; P < .001).Conclusions and Relevance: In this retrospective cohort study of fresh donor oocyte cycles, the number of supernumerary blastocysts to achieve 1 live birth for a given number of fresh donor oocytes exposed to sperm was approximated, which may be valuable for counseling patients.


  • Racial and ethnic disparities in wait times for donor oocytes

    by Shelun Tsai, Nissiya Adjei, Angela D. Svedberg, Anjile An, Callie Rose Sacks, Jonas Malmsten, Zev Rosenwaks, Alexis Melnick


  • Addressing Privacy Concerns Surrounding Oocyte Donation in the United States

    by Shelun Tsai, Jennifer L. Md Eaton

    Oocyte donation has greatly expanded in the past several decades since the first procedure was performed in 1983. According to the Centers for Disease Control, the number of cycles using donor oocytes increased from 18,011 cycles in 2010 to 27,131 cycles in 2019. Oocyte donation has become an important reproductive option for women with diminished ovarian reserve, recurrent failed in vitro fertilization, or heritable genetic conditions. It is also particularly important for single men, same-sex male couples, and men with a transgender woman partner. More recently, societal changes accompanying the expansion of social media and broader access to direct-to-consumer DNA testing have raised concerns about privacy and anonymity. In this article, we review two specific aspects of donor privacy: privacy related to personal identifiers provided by clinics or donor egg bank websites and privacy related to direct-to-consumer genetic testing. We also provide clinical recommendations specific to the United States for working with oocyte donors and donor oocyte recipients.


  • Embryo ploidy in vitrified versus fresh oocytes: Is there a difference?

    by Shelun Tsai, Jasmyn Johal, Jonas Malmsten, Steven Spandorfer

    Purpose To evaluate embryo ploidy in a cohort of patients who underwent preimplantation genetic testing for aneuploidy (PGT-A) with vitrified oocytes compared to fresh oocytes. Methods Patients who underwent their first autologous oocyte vitrification and warming followed by in vitro fertilization (IVF) and trophectoderm biopsy for PGT-A between 1/1/2017 and 12/31/2021 at a single academic institution were included. Patients were compared 1:3 to age-matched controls who underwent their first IVF cycle with fresh oocytes and subsequent trophectoderm biopsy for PGT-A. The primary outcome was the proportions of euploid, mosaic, and aneuploid embryos between those using vitrified versus fresh oocytes. Results 117 patients who cryopreserved a total of 1,272 mature oocytes were included in the study and were matched with 351 controls using fresh oocytes. The average age was 36.9 ± 2.6 years, and the median interval between oocyte vitrification and warming was 38 months. There were similar numbers of mature oocytes (10.9 ± 4.9 vs. 11.1 ± 6.3, P = .67), fertilized oocytes (7.8 ± 4.0 vs. 8.7 ± 5.5, P = .10), and blastocysts per patient (5.1 ± 3.1 vs. 5.8 ± 4.3, P = .10) between those using vitrified versus fresh oocytes. In terms of embryo ploidy results, there were no statistically significant differences in rates of euploidy (40.1% vs. 41.6%), mosaicism (15.7% vs. 12.0%), or aneuploidy (44.3% vs. 46.4%) (P = .06) between the two groups. Conclusions Oocyte vitrification with subsequent warming, fertilization, and trophectoderm biopsy for PGT-A was not associated with adverse chromosomal competence when compared to age-matched controls utilizing fresh oocytes.


  • Association between donor gamete use and supernumerary embryo disposition decisions

    by Shelun Tsai, Jenna S. Hynes, Nicole Zanolli, Douglas Raburn, Anne Z. Steiner

    Purpose The aim of this study is to determine if donor gamete use is associated with patients’ decisions regarding disposition of supernumerary embryos. Methods Patients who intended to undergo an IVF cycle at a single academic center signed an embryo disposition consent form to indicate their disposition preferences for any supernumerary embryos. A retrospective chart review was performed to obtain the embryo disposition declarations and demographic information. The primary outcome was the distribution of embryo disposition choices between patients who used donor gametes compared to patients who did not use donor gametes. Fisher’s exact test was used to compare groups. Logistic regression models were created to determine the association between donor gamete use and disposition decision after adjusting for patient age, body mass index, and nulliparity. Results Five hundred six patients were included. Ninety-one (18.0%) patients used donor gametes [46 (9.0%) donor oocytes, 52 (10.3%) donor sperm]. Patients using donor gametes differed from those not using donor gametes when making decisions concerning death of the patient (P < 0.01), simultaneous death (P = 0.04), separation (P < 0.01), discontinuation of ART (P = 0.01), and time-limited storage (P < 0.01). Most patients, regardless of donor or autologous gamete use, awarded embryos to themselves or their partner if given the option. For patients who did not choose this option, excess embryos were generally awarded to research or discarded rather than donating to another couple. Patients using donor gametes were more likely to award embryos to research over discarding. Conclusion Patients using donor gametes made different choices regarding supernumerary embryo disposition compared to patients not using donor gametes.